Analyst Ratings for Lyell Immunopharma (LYEL)
LYEL Rating Summary
LYEL Price Target Summary
- Highest: $49.00 (Baird)
- Lowest: $12.00 (BofA Securities)
- Average: $34.00
* Over Last 12-Mos
Overall Rating:
NEUTRAL
Rating Trend:
=
Avg. $ Target:
$34.00 (+170.5%)
* Over Last 12-Mos
Rating Score: 5.6 / 10
Percentile Rank: 59%
Rating Score: 5.6 / 10
Percentile Rank: 59%
| Date | Firm | Analyst | Type | Rating (Past) |
PT (Past) |
Start $ (End $) |
% Chg. | Details |
|---|---|---|---|---|---|---|---|---|
| 4/30/2026 | Baird | Jack Allen | New Coverage | Outperform (N/A) |
49.00 (N/A) |
20.60 (12.57) |
-38.98% | Details |
| 4/10/2026 | Needham | Gil Blum | New Coverage | Buy (N/A) |
44.00 (N/A) |
23.85 (12.57) |
-47.3% | Details |
 |
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
|
||||||||
